Denton; R. Rex

Patent Applications and Registrations

Patent applications and USPTO patent grants for Denton; R. Rex.The latest application filed is for "cdk5 genetic markers associated with galantamine response".

Company Profile

0.2.20

Denton; R. Rex - Madison CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CDK5 genetic markers associated with galantamine response App 20080166723 - Aerssens; Jeroen ; et al.	2008-07-10
CDK5 genetic markers associated with galantamine response Grant 7,250,258 - Aerssens , et al. July 31, 2	2007-07-31
NTRK1 genetic markers associated with progression of Alzheimer's disease App 20060166219 - Aerssens; Jeroen ; et al.	2006-07-27
LDLR genetic markers associated with age of onset of Alzheimer's Disease App 20060154265 - Aerssens; Jeroen ; et al.	2006-07-13
Methods for obtaining and using haplotype data Grant 7,058,517 - Denton , et al. June 6, 2	2006-06-06
APOE genetic markers associated with age of onset of Alzheimer's disease App 20050277129 - Aerssens, Jeroen ; et al.	2005-12-15
LRPAP1 genetic markers associated with galantamine App 20050260613 - Aerssens, Jeroen ; et al.	2005-11-24
APOC1 genetic markers associated with age of onset of Alzheimer's Disease App 20050255498 - Aerssens, Jeroen ; et al.	2005-11-17
SLC5A7 genetic markers associated with age of onset of Alzheimer's disease App 20050255495 - Aerssens, Jeroen ; et al.	2005-11-17
CHRNA9 genetic markers associated with progression of Alzheimer's disease App 20050255492 - Aerssens, Jeroen ; et al.	2005-11-17
CDK5 genetic markers associated with galantamine response App 20050255494 - Aerssens, Jeroen ; et al.	2005-11-17
NTRK1 genetic markers associated with age of onset of Alzheimer's Disease App 20050255488 - Aerssens, Jeroen ; et al.	2005-11-17
NTRK2 genetic markers associated with progression of Alzheimer's disease App 20050250121 - Aerssens, Jeroen ; et al.	2005-11-10
EPHX2 Genetic markers associated with galantamine App 20050250118 - Aerssens, Jeroen ; et al.	2005-11-10
APOA4 genetic markers associated with progression of Alzheimer's disease App 20050250122 - Aerssens, Jeroen ; et al.	2005-11-10
Haplotypes of the FCER1A gene App 20050196829 - Chew, Anne ; et al.	2005-09-08
CHRNA2 genetic markers associated with galantamine response App 20050048543 - Aerssens, Jeroen ; et al.	2005-03-03
Haplotypes of the UCP2 gene App 20030207284 - Chew, Anne ; et al.	2003-11-06
Haplotypes of the TNFRSF11B gene App 20030175710 - Chew, Anne ; et al.	2003-09-18
Haplotypes of the TNFRSF1A gene App 20030165844 - Anastasio, Alison E. ; et al.	2003-09-04
Haplotypes of the icam2 gene App 20030082555 - Chew, Anne ; et al.	2003-05-01
Drug target isogenes: polymorphisms in the Interleukin 4 Receptor Alpha gene App 20030078220 - Chew, Anne ; et al.	2003-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.